A substantial number of investigations have reported high infiltration of tumoral CD163+ M2 macrophages and increased PD-L1 expression as independent prognostic factors for poor clinical outcome in various malignancies, including RCC. This evidence concerns the gene CD163 and renal cell carcinoma.